BG108673A - Pharmaceutical composition comprising gamma-butyrobetaine - Google Patents
Pharmaceutical composition comprising gamma-butyrobetaineInfo
- Publication number
- BG108673A BG108673A BG108673A BG10867304A BG108673A BG 108673 A BG108673 A BG 108673A BG 108673 A BG108673 A BG 108673A BG 10867304 A BG10867304 A BG 10867304A BG 108673 A BG108673 A BG 108673A
- Authority
- BG
- Bulgaria
- Prior art keywords
- butyrobetaine
- gamma
- disclosed
- erection
- pharmaceutical compositions
- Prior art date
Links
- JHPNVNIEXXLNTR-UHFFFAOYSA-O 4-(trimethylammonio)butanoic acid Chemical compound C[N+](C)(C)CCCC(O)=O JHPNVNIEXXLNTR-UHFFFAOYSA-O 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 230000001568 sexual effect Effects 0.000 abstract 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 2
- 230000000638 stimulation Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 230000037007 arousal Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-01-134A LV12979B (en) | 2001-09-07 | 2001-09-07 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG108673A true BG108673A (en) | 2005-03-31 |
Family
ID=19735292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG108673A BG108673A (en) | 2001-09-07 | 2004-04-07 | Pharmaceutical composition comprising gamma-butyrobetaine |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20040242590A1 (fr) |
| EP (1) | EP1429753B1 (fr) |
| JP (1) | JP4382480B2 (fr) |
| KR (1) | KR100841035B1 (fr) |
| CN (1) | CN1275595C (fr) |
| AR (1) | AR036423A1 (fr) |
| AT (1) | ATE350029T1 (fr) |
| AU (1) | AU2002236340B2 (fr) |
| BG (1) | BG108673A (fr) |
| CA (1) | CA2459719C (fr) |
| CU (1) | CU23347B6 (fr) |
| DE (1) | DE60217369T2 (fr) |
| DK (1) | DK1429753T3 (fr) |
| EA (1) | EA006675B1 (fr) |
| ES (1) | ES2280505T3 (fr) |
| HR (1) | HRPK20040328B3 (fr) |
| IL (2) | IL160734A0 (fr) |
| JO (1) | JO2507B1 (fr) |
| LV (1) | LV12979B (fr) |
| MA (1) | MA27683A1 (fr) |
| MX (1) | MXPA04002050A (fr) |
| MY (1) | MY134074A (fr) |
| NZ (1) | NZ532178A (fr) |
| PL (1) | PL368758A1 (fr) |
| PT (1) | PT1429753E (fr) |
| SI (1) | SI1429753T1 (fr) |
| TW (1) | TWI224506B (fr) |
| WO (1) | WO2003022262A1 (fr) |
| ZA (1) | ZA200402702B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10325813B4 (de) * | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
| LV13450B (en) * | 2004-08-24 | 2006-11-20 | Grindeks As | Novel medicinal use of meldonium and pharmaceutical compositions thereof |
| AU2006275702A1 (en) | 2005-07-29 | 2007-02-08 | Concert Pharmaceuticals Inc. | Novel pharmaceutical compounds |
| WO2009095445A1 (fr) * | 2008-01-29 | 2009-08-06 | Grindeks | Nouvelle seconde utilisation médicale de 3-(2,2,2-triméthylhydrazine)propionate dihydrate |
| CN101781302B (zh) * | 2009-05-31 | 2013-07-10 | 段波 | 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用 |
| RU2622757C1 (ru) * | 2016-06-02 | 2017-06-19 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | Способ лечения эректильной дисфункции |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1198434B (it) * | 1981-01-06 | 1988-12-21 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina |
| LV11728B (en) | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
| LV11727B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
-
2001
- 2001-09-07 LV LVP-01-134A patent/LV12979B/en unknown
-
2002
- 2002-03-04 WO PCT/LV2002/000004 patent/WO2003022262A1/fr not_active Ceased
- 2002-03-04 EA EA200400386A patent/EA006675B1/ru not_active IP Right Cessation
- 2002-03-04 EP EP02702955A patent/EP1429753B1/fr not_active Expired - Lifetime
- 2002-03-04 DE DE60217369T patent/DE60217369T2/de not_active Expired - Lifetime
- 2002-03-04 PT PT02702955T patent/PT1429753E/pt unknown
- 2002-03-04 KR KR1020047003366A patent/KR100841035B1/ko not_active Expired - Fee Related
- 2002-03-04 NZ NZ532178A patent/NZ532178A/en unknown
- 2002-03-04 US US10/488,840 patent/US20040242590A1/en not_active Abandoned
- 2002-03-04 PL PL02368758A patent/PL368758A1/xx unknown
- 2002-03-04 ES ES02702955T patent/ES2280505T3/es not_active Expired - Lifetime
- 2002-03-04 JP JP2003526391A patent/JP4382480B2/ja not_active Expired - Fee Related
- 2002-03-04 CN CNB028175077A patent/CN1275595C/zh not_active Expired - Fee Related
- 2002-03-04 AT AT02702955T patent/ATE350029T1/de not_active IP Right Cessation
- 2002-03-04 CA CA2459719A patent/CA2459719C/fr not_active Expired - Fee Related
- 2002-03-04 HR HR20040328A patent/HRPK20040328B3/xx not_active IP Right Cessation
- 2002-03-04 DK DK02702955T patent/DK1429753T3/da active
- 2002-03-04 MX MXPA04002050A patent/MXPA04002050A/es active IP Right Grant
- 2002-03-04 SI SI200230507T patent/SI1429753T1/sl unknown
- 2002-03-04 IL IL16073402A patent/IL160734A0/xx unknown
- 2002-03-04 AU AU2002236340A patent/AU2002236340B2/en not_active Ceased
- 2002-08-29 MY MYPI20023224A patent/MY134074A/en unknown
- 2002-09-04 AR ARP020103331A patent/AR036423A1/es unknown
- 2002-09-05 TW TW091120239A patent/TWI224506B/zh not_active IP Right Cessation
- 2002-09-05 JO JO200291A patent/JO2507B1/en active
-
2004
- 2004-03-04 CU CU20040040A patent/CU23347B6/es unknown
- 2004-03-04 IL IL160734A patent/IL160734A/en not_active IP Right Cessation
- 2004-04-05 MA MA27608A patent/MA27683A1/fr unknown
- 2004-04-06 ZA ZA200402702A patent/ZA200402702B/en unknown
- 2004-04-07 BG BG108673A patent/BG108673A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03005464A (es) | Agentes antivirales. | |
| YU69902A (sh) | Novi derivati piperazina | |
| WO2003000343A3 (fr) | Administration d'inhibiteurs de phosphodiesterase destinee au traitement de l'ejaculation precoce | |
| ZA200104396B (en) | Compositions and methods for stimulating gastrointestinal motility. | |
| MA26861A1 (fr) | Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| HUP9802678A2 (hu) | Biciklusos aminszármazékok és ezeket tartalmazó PGD2 antagonista hatású készítmények | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| EA200400007A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ | |
| WO2005056524A3 (fr) | Agents therapeutiques pour traitement de la douleur | |
| HUP0100870A2 (hu) | Analgetikumokként alkalmazható alfa-amino-amid-származékok | |
| WO2005014617A3 (fr) | Compositions de peptides cycliques et methodes pour le traitement d'une dysfonction sexuelle | |
| AU3850600A (en) | Dalda analogs and their use | |
| EP0992240A4 (fr) | Agent therapeutique destine a traiter l'anerection | |
| SE9802206D0 (sv) | Novel compounds | |
| EE200200107A (et) | Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks | |
| IL149586A0 (en) | Pyrimidine derivatives as selective inhibitors of cox-2 | |
| BG108673A (en) | Pharmaceutical composition comprising gamma-butyrobetaine | |
| ATE218535T1 (de) | Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung | |
| UA37278C2 (uk) | Протикашльова фармацевтична композиція для перорального введення | |
| CA2417081A1 (fr) | Derives benzimidazolone n,n'-disubstitues presentant une affinite pour les recepteurs de la serotonine et de la dopamine | |
| EP1616862A4 (fr) | Compose heterocyclique azote et utilisation de celui-ci | |
| WO2004010924A3 (fr) | Medicaments a base de pyrroloquinoline quinone servant d'agent neuroprotecteur et procedes pour les utiliser | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| WO2004084801A3 (fr) | Traitements de la leishmaniose |